Hepalink EffectHi folks.
We all know that many very positive things can happen between now and the BETonMACE trial results in 2018 and many lists have been posted. (epigenetic momentum, regional deals, orphan trials, further understanding of the MOA of rvx-208, success of the 3 month ZEN 3694 prostate cancer trial with results this summer (lends credibility to BET inhibition and hence rvx-208),etc).
One thing that just occurred to me is the potential Hepalink effect. Hepalink is an insider and they will be doing the China, Taiwan, Macau trials. They will probably also be doing their own scientific research on the MOA of rvx-208. They have access to armies of top rate scientists to check out this molecule. Hepalink is a downstream pharma company and the sooner they get rvx-208 to market the sooner their balance sheet improves. Hepalink has a presence in the USA via a takeover in the past few years. Obviously Hepalink already has a strong belief in rvx-208 regarding MACE reduction because they are funding the full BETonMACE trial. Therefore if they begin to sniff a very high probability of BETonMACE success as they move through the trial OR if they begin to understand the applications of rvx-208(or other RVX compounds) for other indications they may move fairly quickly toward a buyout of Resverlogix and perhaps ZEL before other pharma can make the move.I
Don mentioned a possible large deal regarding ZEL or parts thereof in China.
There is a lot going on at both ZCC and RVX in terms of science and deals so perhaps we'll see action of the investment side sooner than later. The momentum is building. This could be the deal that launches Hepalink well above it's current limited portfolio and makes them a significant global player.
Hepalink could be the ace. They have the knowledge and $$$$ to by RVX and if things heat up they may move fast.
The failures by major pharmas using the benzodiazepine scaffold could turn some investors away from epigenetics OR focus them on the ASSURE and SUSTAIN successes with rvx-208.
We'll see but it may not take the full trial before this stock blows through the roof as I had been thinking previously.
GLTA
Toinv
I having problems with SH.